Results for intra-tumoral subsite and CD8+ in oral cavity cancers appeared largely heterogenous (Figure 4)—tumor core and parenchymal CD8+ trended towards an improved survival—while stromal CD8+ was inconclusive. This evidence concerns the gene CD8A and oral cavity cancer.